BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 16909065)

  • 21. Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
    Shaw SY; Shah L; Jolly AM; Wylie JL
    Addiction; 2007 Oct; 102(10):1626-35. PubMed ID: 17854339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual injection risk behavior, HIV infection, and the evaluation of syringe exchange programs.
    Des Jarlais DC; Braine N; Yi H; Turner C
    AIDS Educ Prev; 2007 Apr; 19(2):111-23. PubMed ID: 17411414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.
    Astals M; Domingo-Salvany A; Buenaventura CC; Tato J; Vazquez JM; Martín-Santos R; Torrens M
    Subst Use Misuse; 2008; 43(5):612-32. PubMed ID: 18393080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of HIV risk-behavior and the identification of predictors for sharing injecting materials among young drug users in Prague, Czech Republic.
    Mikl J; Brůcková M; Jedlicka J; Malý M; Vyslouzilová S; Douda I; Minarík J; Smith P; DeHovitz J
    Cent Eur J Public Health; 2001 Nov; 9(4):228-35. PubMed ID: 11787253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective investigation of major depressive disorder and comorbidity in abused and neglected children grown up.
    Widom CS; DuMont K; Czaja SJ
    Arch Gen Psychiatry; 2007 Jan; 64(1):49-56. PubMed ID: 17199054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
    Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
    Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychiatric comorbidity in risk groups of opioid addiction: a comparison between opioid dependent and non-opioid dependent prisoners (in jail due to the German narcotics law)].
    Franke P; Neef D; Weiffenbach O; Gänsicke M; Hautzinger M; Maier W
    Fortschr Neurol Psychiatr; 2003 Jan; 71(1):37-44. PubMed ID: 12529833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychopathology and transmission risk behaviors in patients with HIV/AIDS.
    Newville H; Haller DL
    AIDS Care; 2010 Oct; 22(10):1259-68. PubMed ID: 20640950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term effects of syringe exchange on risk behavior and HIV prevention.
    Braine N; Des Jarlais DC; Ahmad S; Purchase D; Turner C
    AIDS Educ Prev; 2004 Jun; 16(3):264-75. PubMed ID: 15237055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between generalized social phobia and avoidant personality disorder in a national mental health survey.
    Cox BJ; Pagura J; Stein MB; Sareen J
    Depress Anxiety; 2009; 26(4):354-62. PubMed ID: 19031488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisocial personality disorder is associated with increased severity of gambling, medical, drug and psychiatric problems among treatment-seeking pathological gamblers.
    Pietrzak RH; Petry NM
    Addiction; 2005 Aug; 100(8):1183-93. PubMed ID: 16042649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief.
    Simon NM; Shear KM; Thompson EH; Zalta AK; Perlman C; Reynolds CF; Frank E; Melhem NM; Silowash R
    Compr Psychiatry; 2007; 48(5):395-9. PubMed ID: 17707245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between parental and individual psychiatric/substance use disorders and smoking stages among Puerto Rican adolescents.
    Dierker LC; Canino G; Merikangas KR
    Drug Alcohol Depend; 2006 Sep; 84(2):144-53. PubMed ID: 16481127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary syringe exchange among users of 23 California syringe exchange programs.
    Lorvick J; Bluthenthal RN; Scott A; Gilbert ML; Riehman KS; Anderson RL; Flynn NM; Kral AH
    Subst Use Misuse; 2006; 41(6-7):865-82. PubMed ID: 16809176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antisocial personality disorder and HIV infection among intravenous drug abusers.
    Brooner RK; Greenfield L; Schmidt CW; Bigelow GE
    Am J Psychiatry; 1993 Jan; 150(1):53-8. PubMed ID: 8417580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).
    Miller CL; Strathdee SA; Li K; Kerr T; Wood E
    Am J Drug Alcohol Abuse; 2007; 33(4):527-36. PubMed ID: 17668338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of antisocial personality disorder and substance disorder morbidity in a clinical sample.
    Westermeyer J; Thuras P
    Am J Drug Alcohol Abuse; 2005; 31(1):93-110. PubMed ID: 15768573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adolescent substance abuse and psychiatric comorbidities.
    Deas D
    J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.